Acadia Pharmaceuticals Inc. (ACAD)

[EFHutton7]

Extraneous factors are of course helping to bring down biotech and with it ACAD, however add to that managements continued and predictably ongoing missteps and you have the makings for a severe downdraft the next 2-3 months.
Eg, they have what, over 100 highly compensated reps in the field.
Let's say they are at a docs today and the doc asks them the simplest of all questions, 'what's the price?'.
And they can't answer because management hasn't got that far yet.
Despicable.
They are the laughing stock of the industry, and THAT isn't fully baked in yet.
Wait until he speaks again tomorrow.